Patent Assignment
Reel/Frame 062205/0883
First Amendment to Ip Security Agreement
Recorded: 2022-12-22
Pages: 34
Assignor
KALA PHARMACEUTICALS, INC.
Executed: 2022-12-19
Assignee
OXFORD FINANCE LLC
115 SOUTH UNION STREET, SUITE 300, ALEXANDRIA, VIRGINIA, 22314
Covered Properties
(59)
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Urea Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Meropenem Derivatives and Uses Thereof
Compounds for Treatment of Diseases of Abnormal Angiogenesis or Aberrant Growth Factors and Uses Thereof
Urea Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Urea Derivatives and Uses Thereof
Crystalline Forms of a Therapeutic Compound and Uses Thereof
1-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Meropenem Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Urea Derivatives and Uses Thereof
Urea Derivatives and Uses Thereof
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Novel Compounds and Uses Thereof
Novel Compounds and Uses Thereof
Urea Derivatives and Uses Thereof
Urea Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
1-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Urea Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Novel Compounds and Uses Thereof
Meropenem Derivatives and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Targeted in Situ Therapeutic Delivery of Secreted Factors from Stem Cells for Treatment of Damaged Tissue
Biochemical binding of RET9 and VEGFR2 inhibitors
Processes for Making and Using a Mesenchymal Stem Cell Derived Secretome
Processes for Making and Using a Mesenchymal Stem Cell Derived Secretome
Patent:
10,758,571 →
Application:
16/785,470 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Processes for Making and Using a Mesenchymal Stem Cell Derived Secretome
Urea Derivatives and Uses Thereof
Therapeutic Compounds and Uses Thereof
Processes for Making and Using a Mesenchymal Stem Cell Derived Secretome
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Lyophilized Mesenchymal Stem Cell Derived Secretome and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application:
17/315,080 →
Publication:
US 2021/0261562
Therapeutic Compounds and Uses Thereof
Application:
17/747,754 →
Publication:
US 2023/0116686
Processes for Making a Cellular Fibronectin Composition
Cellular Fibronectin Compositions
Methods and Assays for Secretome Activity Analysis
Application:
63/359,743 →
Preparation and Purification Methods for Mesenchymal Stem Cell Derived Secretome
Application:
63/404,455 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 6, 2014
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 032829/0966 →
Assignment of Assignor's Interest
May 6, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032829/0862 →
Assignment of Assignor's Interest
May 6, 2014
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032829/0986 →
Assignment of Assignor's Interest
May 9, 2014
From: ASKEW, BEN
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 032861/0868 →
Assignment of Assignor's Interest
May 9, 2014
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032861/0976 →
Assignment of Assignor's Interest
May 9, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032861/0803 →
Assignment of Assignor's Interest
Aug 8, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO; NGUYEN, MINH NGOC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 033493/0135 →
Assignment of Assignor's Interest
Nov 6, 2014
From: ENLOW, ELIZABETH; NGUYEN, MINH NGOC; ONG, WINSTON Z
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 034113/0739 →
Assignment of Assignor's Interest
Sep 25, 2015
From: POPOV, ALEXEY; ENLOW, ELIZABETH M.; CHEN, HONGMING; BOURASSA, JAMES
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 036662/0213 →
Assignment of Assignor's Interest
Sep 25, 2015
From: ONG, WINSTON Z.; NOWAK, PAWEL W.; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 036661/0915 →
Assignment of Assignor's Interest
Sep 25, 2015
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 036661/0974 →
Assignment of Assignor's Interest
Sep 25, 2015
From: BREAKTROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 036662/0081 →
Assignment of Assignor's Interest
Dec 28, 2015
From: ENLOW, ELIZABETH; NGUYEN, MINH NGOC; ONG, WINSTON Z
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 037368/0668 →
Assignment of Assignor's Interest
Jan 28, 2016
From: ASKEW, BEN C.; GOOD, ANDREW; ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 037609/0089 →
Assignment of Assignor's Interest
Mar 15, 2016
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; FEUTRILL, JOHN THOMAS; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 037990/0294 →
Assignment of Assignor's Interest
Mar 15, 2016
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; FEUTRILL, JOHN THOMAS; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 037980/0266 →
Assignment of Assignor's Interest
Apr 27, 2016
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 038398/0420 →
Assignment of Assignor's Interest
Apr 27, 2016
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 038398/0440 →
Assignment of Assignor's Interest
Apr 27, 2016
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 038398/0380 →
Assignment of Assignor's Interest
May 10, 2016
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 038538/0905 →
Assignment of Assignor's Interest
May 10, 2016
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 038538/0977 →
Assignment of Assignor's Interest
May 10, 2016
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 038539/0133 →
Assignment of Assignor's Interest
May 10, 2016
From: ENLOW, ELIZABETH; NGUYEN, MINH NGOC; ONG, WINSTON Z.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 038539/0266 →
Confirmatory License
Mar 21, 2017
From: KALA PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042045/0236 →
Assignment of Assignor's Interest
May 12, 2017
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; FEUTRILL, JOHN THOMAS; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 042355/0716 →